Explore Protagenic Therapeutics' 8-K filing from February 21, 2025, detailing stock info and corporate developments. Key insights for investors and analysts.
Explore Nuvve Holding Corp.'s 8-K report detailing equity structure, common stock, and warrants. Key insights on filing date, corporate info, and securities.
Explore Cycurion, Inc.'s 8-K filing from February 24, 2025, detailing stock metrics, compliance, and financial insights.
Explore Global Star Acquisition Inc.'s latest 8-K filing revealing stock details and financial strategies. Key insights into Class A Common Stock, redeemable warrants, and rights.
Explore Cipher Mining Inc.'s 8-K filing detailing common stock and warrant info, including par value and exercise price. Key insights for investors on equity instruments and funding strategies.
Explore IVEDA Solutions' significant 8-K filing dated February 21, 2025, detailing stock information, warrants, and corporate updates.
Explore Occidental Petroleum's 8-K filing detailing common stock and warrants with a $0.20 par value. This report highlights important corporate activities as of March 3, 2025.
Explore Lottery.com Inc.'s 8-K filing revealing stock details, warrants, and financial insights as of February 20, 2025. Key for investors tracking LTRY on NASDAQ.
Explore PureCycle Technologies, Inc.'s 8-K filing detailing stock and warrant offerings, regulatory compliance, and growth strategies. Key insights for investors and analysts.
Explore Celularity Inc.'s February 2025 8-K report detailing Class A Common Stock and warrants on NASDAQ. Key financial insights and trading symbols included.
Explore Safety Shot, Inc.'s 8-K filing from February 24, 2025, highlighting stock performance, warrants, and regulatory compliance. Key metrics for investors included.
Explore Protagenic Therapeutics, Inc.'s 8-K filing from February 21, 2025, covering stock details, trading symbols, and entity information. Key insights into PTIX and PTIXW.